POINT Biopharma Global Inc.
PNTDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811764
POINT Biopharma Global Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 27, 2023; 126 institutions reported holding it in 13F filings for Q3 2023, worth $411.0M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding POINT Biopharma Global Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 126 | 1 | 1 | −124 |
| Shares | 61.6M | 20.0K | 127 | −61.6M (−100.0%) |
| Value | $411.0M | $133.4K | $1.00K | −$410.8M (−100.0%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held POINT Biopharma Global Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ronald Blue Trust, Inc. | 127 | $1.00K | 0.00% |
Sold out (125)
Institutions that held POINT Biopharma Global Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
Showing the largest 100 of 125 by value.
Not filed for Q4 2023 yet (1)
Institutions that held POINT Biopharma Global Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| First Republic Investment Management, Inc. | 20,000 | $133.4K |